/

SHL.AX

SONIC HLTH FPO [SHL]Closed

18.37−0.02 −0.11%AUD

ASX · as of Oct 14, 01:11 ET · 20m delay

Open

18.35

Prev close

18.39

Day range

18.1818.41

52-week range

18.1124.27

Volume

1.28M0.43×

Mkt cap

9.08B

P/E ttm

14.93

Fwd P/E

14.06

EPS ttm

1.23

Div yield

5.87%

Earnings

Aug 20, 2026

From 52w high

−24.31%

Price Chart

Yahoo Finance · delayed

SHL.AXOct 14, 2026O 18.35H 18.41L 18.18C 18.37−0.02 (−0.11%)Vol 1.28M

SMA 5019.98
SMA 20020.76

1Y change −12.73% since Oct 13, 2025 close547 bars loadedTimes in Australia/SydneyDraw from the left toolbar · click a drawing to edit · right-click for alerts and export

SHL.AX SONIC HLTH FPO [SHL] · Last Guard Finance

DES

Key Statistics

Yahoo Finance

Performance

1 week: −2.44%
1 month: −3.57%
3 months: −14.48%
6 months: −10.22%
Year to date: −18.75%
1 year: −11.47%

Valuation & ownership

Market cap: 9.08B
Enterprise value: 14.43B
P/E (ttm): 14.93
Forward P/E: 14.06
PEG ratio: 2.30
Price / book: 1.09
Price / sales (ttm): 0.84
EV / EBITDA: 10.74
EPS (ttm): 1.23
EPS (forward): 1.31
Beta (5y monthly): 0.57
Dividend yield: 5.87%
Payout ratio: 87.80%
Shares outstanding: 494.24M
Float: 459.82M
Short % of float: —
Short ratio (days): —
Held by insiders: 7.99%
Held by institutions: 50.22%
Avg volume (3m): 2.98M
50-day average: 20.06
200-day average: 20.77
52-week change: −11.47%
S&P 500 52-week: +17.03%

Technicals (daily)

RSI (14): 35.7
vs 50-day SMA: −7.70%
vs 200-day SMA: −11.42%
50 / 200-day trend: ▼ 50 below 200
MACD vs signal: ▲ above
ATR (14) % of price: 1.96%
Realised vol (20d, ann.): 16.6%
From 52-week high: −24.31%
From 52-week low: +1.44%

ANR

Analyst Consensus

16 analysts

Consensus

Hold

3.00 on a 1 (strong buy) – 5 (sell) scale

Mean target

22.12

+20.40% implied

Low 19.20Median 21.60High 27.50

Recommendation trend

Now3 / 10 / 3
1m ago

DES

About SONIC HLTH FPO [SHL]

Yahoo Finance profile

Sonic Healthcare Limited offers medical diagnostic services, and administrative services and facilities to medical practitioners in Australia, the United States, Germany, and internationally. The company provides laboratory medicine/pathology testing services, such as biochemistry, cytopathology, genetics, haematology, histopathology, immunoserology, microbiology, molecular pathology, prenatal testing, toxicology, and ancillary functions; and radiology services, including magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, X-ray, mammography, nuclear medicine, PET CT, interventional procedures, and bone mineral densitometry (BMD). It also offers primary care medical services comprising general practice clinics, occupational health services, skin cancer clinics, general practice IT solutions, and community-based healthcare services, as well as clinical trials and chronic disease management program services. Sonic Healthcare Limited was incorporated in 1934 and is headquartered in Sydney, Australia.

Sector: Healthcare
Industry: Diagnostics & Research
Employees: 47,000
Headquarters: Sydney, NSW, Australia
Website: sonichealthcare.com
Officers: Dr. James Pacey Newcombe MD, CEO & Executive Director
Mr. Christopher David Wilks B.Com., F.A.C.I.D., F.A.I.C.D. Finance Director, CFO & Executive Director

SEAS

Seasonality · SHL.AX

2007–2026 · monthly returns

Strongest month Jun +3.10%Weakest month Sep −3.57%Averages use completed years only. Past seasonality doesn't predict future returns.

Year	Jan	Feb	Mar	Apr	May	Jun	Jul	Aug	Sep	Oct	Nov	Dec	Year
2026	1.5	3.8	-14.2	-3.3	-1.3	6.6	5.0	-10.4	-3.1	-3.3			−18.8%
2025	5.7	-3.9	-6.2	1.2	2.3	0.4	3.1	-12.9	-10.9	-1.3	10.3	-3.1	−16.3%
2024	-0.2	-6.8	-1.5	-9.0	-9.1	8.1	5.2	0.1	-1.6	-1.1	6.1	-5.5	−15.8%
2023	5.4	2.0	8.2	1.7	-0.7	1.1	-1.2	-8.5	-7.3	-3.5	1.5	10.0	+7.0%
2022	-18.7	-7.5	1.2	3.5	-0.2	-10.0	3.8	-0.8	-10.1	7.2	-1.5	-7.2	−35.7%
2021	6.9	-7.7	10.6	2.3	-3.0	10.4	4.2	8.4	-6.3	-1.5	6.7	9.2	+45.0%
2020	10.2	-9.1	-15.5	11.8	3.6	8.0	5.5	-0.2	3.5	5.0	-5.4	-2.4	+11.8%
2019	4.1	4.8	1.8	4.4	1.9	3.6	3.5	5.0	-4.8	1.7	5.5	-4.5	+30.0%
2018	4.3	2.7	-6.6	3.2	-0.3	4.1	6.3	0.4	-4.9	-9.5	1.1	-3.0	−3.3%
2017	-2.7	3.4	2.8	-0.1	4.8	4.6	-8.0	-1.7	-4.5	4.1	2.3	2.6	+6.8%
2016	3.0	-0.1	2.2	3.4	10.2	0.7	6.6	0.1	-4.3	-6.9	6.4	-1.8	+19.8%
2015	1.8	3.2	5.1	-2.8	1.1	6.4	-3.3	0.2	-11.9	5.6	5.4	-12.1	−3.4%
2014	-0.4	5.2	-0.6	2.5	0.1	-2.1	4.8	-3.0	-0.5	6.5	-6.6	6.0	+11.6%
2013	2.6	-1.8	3.7	-4.8	7.3	4.1	-3.4	8.0	4.8	-0.3	2.8	-0.1	+24.4%
2012	-0.4	7.2	4.0	0.7	-3.3	4.1	-0.4	6.0	1.0	-4.1	3.4	-0.8	+18.2%
2011	2.9	-5.5	6.2	4.5	-1.8	4.6	-5.7	-3.2	-3.0	-3.2	4.3	-2.0	−2.8%
2010	-7.7	-4.5	6.1	-4.0	-25.9	2.1	-1.2	7.3	-0.5	-1.0	8.4	-1.8	−24.5%
2009	-4.5	-13.7	-7.8	5.3	1.5	4.1	-5.0	19.5	1.6	-1.3	1.1	8.5	+5.6%
2008	-2.5	-12.0	-4.2	10.9	-5.6	1.0	-4.6	4.3	-9.5	4.7	-2.3	8.7	−12.9%
2007	-2.6	-3.0	4.9	-3.1	1.9	3.4	2.3	0.1	1.2	10.4	-2.8	-0.1	+12.4%

INSD

Insider Activity · SHL.AX

Market-wide insider buying →Congress trades →SEC Form 4 filings via Yahoo Finance

Buys, 6 months

0 shares

Sells, 6 months

— shares

Net shares

Net change in insider shares

—

Date	Insider	Transaction	Shares	Value
Oct 15, 2025	Evans (Nicola Wakefield)Director (Non-Executive)	Purchase at price 14.12 per share.	2.5K	$35.30K
Oct 14, 2025	Giles (Katharine M.D.)Independent Non-Executive Director	Purchase at price 13.78 per share.	1K	$13.78K
Oct 2, 2025	Giles (Katharine M.D.)Independent Non-Executive Director	Purchase at price 14.34 per share.	1K	$14.34K
Oct 1, 2025	Compton (Mark Raymond)Chairman of the Board	Purchase at price 14.23 per share.	1.5K	$21.34K
Sep 30, 2025	Bennett (Christine)Independent Non-Executive Director	Purchase at price 14.22 per share.	1.1K	$15.64K
Sep 28, 2025	Goldschmidt (Colin Stephen)Chief Executive Officer	—	10.2K	—
Sep 28, 2025	Wilks (Christopher David)Director (Executive)	—	5.9K	—
Sep 25, 2025	Crowe (Suzanne)Independent Non-Executive Director	Purchase at price 13.83 per share.	2.4K	$32.70K
Sep 25, 2025	Spargo (Kathryn Dianne)Independent Non-Executive Director	Purchase at price 13.92 per share.	3.5K	$48.72K
Sep 1, 2025	Goldschmidt (Colin Stephen)Chief Executive Officer	—	9.9K	—
Sep 1, 2025	Wilks (Christopher David)Director (Executive)	—	3.8K	—
Apr 8, 2025	Bennett (Christine)Independent Non-Executive Director	Purchase at price 15.38 per share.	1K	$15.38K
Apr 7, 2025	Giles (Katharine M.D.)Independent Non-Executive Director	Purchase at price 14.72 per share.	850	$12.51K
Mar 24, 2025	Evans (Nicola Wakefield)Director (Non-Executive)	Purchase at price 16.13 per share.	2K	$32.26K
Feb 9, 2025	Evans (Nicola Wakefield)Director	—	2K	—
Dec 10, 2024	Bennett (Christine)Independent Non-Executive Director	Purchase at price 18.14 per share.	1K	$18.14K
Dec 9, 2024	Compton (Mark Raymond)Chairman of the Board	Purchase at price 18.14 per share.	1K	$18.14K
Dec 9, 2024	Spargo (Kathryn Dianne)Independent Non-Executive Director	Purchase at price 18.18 per share.	1.5K	$27.26K
Dec 8, 2024	Crowe (Suzanne)Independent Non-Executive Director	Purchase at price 18.48 per share.	348	$6.43K
Nov 5, 2024	Giles (Katharine M.D.)Independent Non-Executive Director	Purchase at price 18.97 per share.	250	$4.74K

SHL.AX

Price Chart

Keyboard shortcuts & functions

Anywhere

Command line

Charts (click the chart first)

Function codes

SHL.AX

Price Chart

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SONIC HLTH FPO [SHL]

Seasonality · SHL.AX

Insider Activity · SHL.AX

Congress Trades · SHL.AX

Investors Holding SHL.AX

Investors Holding SHL.AX

Congress Trades · SHL.AX

Insider Activity · SHL.AX

Seasonality · SHL.AX

Key Statistics

Performance

Valuation & ownership

Technicals (daily)

Analyst Consensus

About SONIC HLTH FPO [SHL]

Financial Snapshot

Earnings & Dividends

News